Performance Food Group insider trades: vested awards and Rule 10b5‑1 sales
Rhea-AI Filing Summary
Erika T. Davis, Executive Vice President and Chief Human Resources Officer of Performance Food Group Company (PFGC), reported multiple equity transactions on 08/19/2025. The Form 4 shows two non‑cash acquisitions: a performance‑based restricted stock grant of 13,616 shares that vested based on relative total shareholder return for the July 3, 2022–June 28, 2025 performance period, and a restricted stock grant of 6,444 shares that vests in three equal annual installments beginning August 19, 2026. The filing also records dispositions totaling 6,513 shares (4,984 shares via Code F at a weighted average price of $99.32 and two sales under a Rule 10b5‑1 plan of 1,100 and 429 shares at weighted averages of $99.55 and $99.91). Following these transactions, Ms. Davis beneficially owned 59,689 shares.
Positive
- Performance‑based award vested: 13,616 shares vested upon committee certification tied to relative total shareholder return for a three‑year performance period.
- Retention award granted: 6,444 restricted shares with three‑year annual vesting beginning August 19, 2026, supporting executive retention.
- Net increase in shares held: Acquisitions (20,060 shares) exceeded dispositions (6,513 shares), increasing beneficial ownership by 13,547 shares to 59,689 shares.
Negative
- Insider sales executed: Dispositions of 6,513 shares were reported, including 4,984 shares sold under Code F and 1,529 shares sold under a Rule 10b5‑1 plan, which could be perceived as liquidity actions by the insider.
Insights
TL;DR: Insider received performance and time‑vested restricted stock while executing planned sales under a 10b5‑1 plan; net shareholding increased.
The transactions show compensation delivery via equity and disciplined selling. A performance‑based grant of 13,616 shares vested on certification of performance for a three‑year TSR period, aligning pay with shareholder returns. A separate 6,444‑share restricted award adds time‑based retention through 2026 and beyond. Dispositions total 6,513 shares, executed partly under a pre‑existing Rule 10b5‑1 plan and partly as a Code F disposition; sale prices cluster around $99.3–$99.9, consistent with orderly plan sales rather than ad hoc liquidation. Beneficial ownership moved from prior levels to 59,689 shares after the activity.
TL;DR: Equity grants and 10b5‑1 sales reflect routine compensation and compliance practices, not an unexpected governance concern.
The filing documents standard practices: performance‑based grants tied to relative TSR and time‑vested restricted stock for retention. The reporting includes a Rule 10b5‑1 plan established Feb 27, 2025, used for part of the sales, which supports compliance with insider trading rules. The mix of vested performance awards and scheduled vesting for new restricted stock is typical of executive compensation design to incentivize long‑term alignment while allowing preplanned liquidity through trading plans.